Use of matrix metalloproteinase inhibitors for treating neurological disorders and promoting wound healing
US6340709B1 · kind B1 · utility
5Cited by
2References
8Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Mar 19, 1999 |
| Grant date | Jan 22, 2002 |
| Priority date | — |
| Expiry date | Mar 19, 2019 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K2800/28
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
This invention provides a method for treating and preventing neurological disorder such as Alzheimer's disease, and for promoting wound healing comprising administering a compound characterized as being a matrix metalloproteinase inhibitor.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.